Effects of novel glucose-lowering drugs on the lipid parameters: A systematic review and meta-analysis

AIM: We aim to evaluate the impacts of sodium-glucose co-transporter 2 inhibitors (SGLT-2), glucagon-like peptide 1 agonist (GLP-1RAs), and dipeptidyl peptidase-four (DPP4) inhibitors on the levels of high-density lipoprotein, low-density lipoprotein, triglyceride and total cholesterol. METHODS: The...

Descripción completa

Detalles Bibliográficos
Autores principales: Dar, Sophia, Siddiqi, Ahmed Kamal, Alabduladhem, Tamim Omar, Rashid, Ahmed Mustafa, Sarfraz, Saba, Maniya, Talha, Menezes, Ritesh G., Almas, Talal
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2022
Materias:
Systematic Review / Meta-analysis
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9142616/
https://www.ncbi.nlm.nih.gov/pubmed/35637990
http://dx.doi.org/10.1016/j.amsu.2022.103633

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9142616/
https://www.ncbi.nlm.nih.gov/pubmed/35637990
http://dx.doi.org/10.1016/j.amsu.2022.103633

Ejemplares similares